NRC Stock Summary and Trading Ideas (National Research | NASDAQ:NRC)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

National Research trades on the NASDAQ stock market under the symbol NRC.

As of December 18, 2025, NRC stock price climbed to $19.30 with 102,400 million shares trading.

NRC has a beta of 0.63, meaning it tends to be less sensitive to market movements. NRC has a correlation of 0.04 to the broad based SPY ETF.

NRC has a market cap of $437.29 million. This is considered a Small Cap stock.

In the last 3 years, NRC traded as high as $47.60 and as low as $9.76.

The top ETF exchange traded funds that NRC belongs to (by Net Assets): VTI, IWM, VXF, DES, IWO.

NRC has underperformed the market in the last year with a return of +11.9%, while SPY returned +13.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NRC shares. However, NRC has outperformed the market in the last 3 month and 2 week periods, returning +22.1% and +19.4%, while SPY returned +2.9% and -1.1%, respectively. This indicates NRC has been having a stronger performance recently.

NRC support price is $17.95 and resistance is $19.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NRC shares will trade within this expected range on the day.